OUR MISSION
At Bio Conscious Technologies, our team of medical and technology professionals apply leading edge machine learning to revolutionize how the world understands glucose
THE DRIVING FORCE
OUR SCIENCE / OUR PRODUCTS
PLAN
PREPARE
PROTECT

OUR PRODUCT

Forecasts diabetes events, enabling clinicians and patients to take preventive actions
AI-powered decision support to assist clinicians
Compatible with Abbott & Dexcom
Increases clinical efficiency and reduces per patient operating costs
Integrates with major EHR/EMR systems
AI-powered auto-charting & billing
Curious about how Endobits can elevate your practice?
Discover Endobits
Dr. Jerome Fischer
Chief Medical Officer & Renowned Endocrinologist
Level 3 AI
Focusing on holistic health management

We are pioneers at the intersection of Glucose and AI
01
Predict
We began our journey with a consumer-focused app that helped people living with diabetes predict and forecast diabetic events
02
Prioritize
Our Endobits Automated Remote Patient Monitoring solution incorporates technology on par with human capability in analyzing CGM data, providing clinical decision-support to drive better patient outcomes


03
Prevent
Recognizing glucose as the 5th vital sign, our technology will inform the identification, treatment and management of chronic diseases beyond diabetes
PARTNERSHIP: DEXCOM + ENDOBITS
Bioconscious Technologies is proud to announce a strategic API integration with Dexcom, a leader in continuous glucose monitoring (CGM) systems. This collaboration allows Endobits to seamlessly integrate Dexcom’s real-time glucose data, enhancing clinicians’ ability to deliver personalized care and empowering patients with actionable insights to manage their diabetes more effectively.
IN THE NEWS
Explore our blog for the latest news in glucose monitoring, tips for managing diabetes, and updates on our technology. Join our community dedicated to health and wellness.
Learn more about Our Timeline


KRPC, Houston
May 9, 2024
How AI is helping to detect pre-diabetes
Dr. Jerome Fischer
CMO, Endocrinologist
Bio Conscious Announces the Integration of GPT 4 LLM Into Its State-of-the-Art Endobits V5 - Creating a Unique Industry-Leading CGM Platform for Diabetes Care

Yahoo Finance
April 25, 2024


May 1, 2024
Amir Hayeri
Founder & CEO
The endobits algorithm discovered a surprising link between diabetes and dementia
© 2015 - 2024 Bio Conscious Technologies Inc.